Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 24% ± 4% | |
| retinal rod cell | 3 studies | 20% ± 1% | |
| GABAergic neuron | 3 studies | 24% ± 4% | |
| glutamatergic neuron | 3 studies | 34% ± 6% | |
| basal cell | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 531.84 | 245 / 245 | 100% | 16.52 | 501 / 502 |
| ovary | 100% | 839.40 | 180 / 180 | 100% | 13.83 | 428 / 430 |
| thymus | 100% | 522.97 | 652 / 653 | 100% | 15.87 | 602 / 605 |
| breast | 100% | 583.38 | 459 / 459 | 99% | 22.63 | 1110 / 1118 |
| adrenal gland | 100% | 578.61 | 258 / 258 | 99% | 14.95 | 228 / 230 |
| brain | 100% | 635.97 | 2637 / 2642 | 99% | 15.52 | 700 / 705 |
| skin | 100% | 684.31 | 1808 / 1809 | 98% | 20.44 | 464 / 472 |
| bladder | 100% | 564.52 | 21 / 21 | 98% | 15.48 | 492 / 504 |
| esophagus | 100% | 415.78 | 1439 / 1445 | 97% | 14.82 | 178 / 183 |
| uterus | 99% | 509.62 | 169 / 170 | 96% | 16.72 | 442 / 459 |
| kidney | 100% | 401.49 | 89 / 89 | 94% | 9.04 | 847 / 901 |
| intestine | 100% | 487.10 | 964 / 966 | 93% | 14.15 | 492 / 527 |
| pancreas | 95% | 236.95 | 310 / 328 | 98% | 11.65 | 175 / 178 |
| lung | 95% | 434.17 | 551 / 578 | 97% | 16.21 | 1121 / 1155 |
| liver | 100% | 629.41 | 226 / 226 | 92% | 7.97 | 372 / 406 |
| stomach | 100% | 440.44 | 358 / 359 | 88% | 11.95 | 251 / 286 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 17.17 | 29 / 29 |
| muscle | 100% | 681.99 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 877.21 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.70 | 1 / 1 |
| adipose | 100% | 536.88 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 98% | 340.35 | 1308 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 555.59 | 843 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 14.58 | 44 / 45 |
| peripheral blood | 82% | 693.24 | 766 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 71% | 4.83 | 57 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0009048 | Biological process | dosage compensation by inactivation of X chromosome |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0001740 | Cellular component | Barr body |
| GO_0016363 | Cellular component | nuclear matrix |
| GO_0000781 | Cellular component | chromosome, telomeric region |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0034451 | Cellular component | centriolar satellite |
| GO_0042974 | Molecular function | nuclear retinoic acid receptor binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | LRIF1 |
| Protein name | Ligand-dependent nuclear receptor-interacting factor 1 (HP1-binding protein enriched in inactive X chromosome protein 1) (HBiX1) (Receptor-interacting factor 1) |
| Synonyms | C1orf103 RIF1 |
| Description | FUNCTION: Together with SMCHD1, involved in chromosome X inactivation in females by promoting the compaction of heterochromatin . Also able to repress the ligand-induced transcriptional activity of retinoic acid receptor alpha (RARA), possibly through direct recruitment of histone deacetylases . Also required for silencing of the DUX4 locus in somatic cells . . |
| Accessions | ENST00000485275.2 [Q5T3J3-2] ENST00000494675.5 [Q5T3J3-2] Q5T3J3 ENST00000369763.5 [Q5T3J3-1] |
